Fluorouracil (5-FU) and calcipotriene are two topical medications that, when mixed together and applied to sun-damaged skin, can clear precancerous spots called actinic keratoses far more effectively than fluorouracil alone. In a randomized trial of 132 participants, a short course of the combination reduced actinic keratoses on the face by roughly 86%, compared with about 26% for fluorouracil by itself.1Journal of Investigative Dermatology. Topical calcipotriol plus 5-fluorouracil immunotherapy for non-keratinocyte skin cancers The practical appeal is that treatment can be as short as four to five days, rather than the multi-week courses fluorouracil traditionally requires. The details of how to mix, apply, and manage side effects matter, and newer expert guidelines have begun refining the protocol by body site.
Why the Combination Works Better Than Fluorouracil Alone
Fluorouracil is a chemotherapy cream that kills rapidly dividing cells. On its own, it does a decent job of destroying precancerous keratinocytes, but it relies almost entirely on direct toxicity. Calcipotriene is a synthetic form of vitamin D normally prescribed for psoriasis. It does not kill abnormal cells on its own, but when paired with fluorouracil it triggers the skin to produce a signaling protein called TSLP. That signal recruits immune cells, particularly CD4+ T cells, into the treated skin. In the original trial, the combination caused a large wave of T cells to flood into the precancerous lesions, peaking around days ten to eleven after treatment, without the pain, crusting, or ulceration that typically accompanies a full course of fluorouracil alone.2PubMed Central. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy
This immune boost is why the combination clears so many more lesions in so many fewer days. Fluorouracil handles the initial damage, and then the immune system follows up to mop up the remaining abnormal cells. Follow-up research showed that this immune response also generates long-lived memory T cells in the skin, which appear to provide ongoing surveillance against future precancerous changes.3PubMed Central. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention In other words, the combination is not just treating the spots you can see today; it is training the skin’s immune defenses to catch future problems earlier.
How to Mix and Apply the Two Medications
There is no single pre-mixed product for this combination. You will typically receive two separate prescriptions: 5% fluorouracil cream (commonly sold as Efudex or a generic) and 0.005% calcipotriene ointment (Dovonex or generic calcipotriol). You mix equal parts of each on your fingertip or a small dish right before applying. A 1:1 ratio is the standard used in the clinical trials. Some dermatologists prescribe a compounded version that comes pre-mixed from a pharmacy, which is more convenient but may affect insurance coverage.4Journal of Investigative Dermatology. Prescription Trends of Fluorouracil with Calcipotriene for Actinic Keratoses in Commercial and Medicare Populations
Apply the mixture in a thin layer to the entire area your dermatologist has designated, not just to individual visible spots. This is called “field treatment” because actinic damage usually extends beyond the lesions you can count. The idea is to treat the whole sun-damaged field so subclinical damage also gets addressed. You apply twice daily, morning and evening. Wash your hands thoroughly after each application, and avoid getting the mixture near your eyes, lips, or mucous membranes. A pea-sized amount typically covers a palm-sized area of skin, though your dermatologist can give you guidance calibrated to the extent of your treatment area.
Treatment Duration by Body Site
One of the most practical developments in this therapy has been expert panel recommendations from the International Society for Cutaneous Carcinomas (ITSCC) that tailor treatment length to the specific body site. Thinner, more sensitive skin on the face and neck responds faster, while thicker skin on the scalp, trunk, and limbs needs a longer course.
For actinic keratoses, the recommended duration is four to five days of twice-daily application on the face and neck, and seven to ten days on the scalp, trunk, and extremities. For squamous cell carcinoma in situ (Bowen’s disease), the durations are a bit longer: seven to ten days on the face and neck, and ten to fourteen days on the scalp, trunk, and extremities.5PubMed. Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi expert panel recommendations from ITSCC These ranges give your dermatologist room to adjust based on how your skin responds and how severe the damage is.
The landmark trial that put this combination on the map used a four-day protocol, which is why you will sometimes hear the shorthand “the four-day treatment.” That original protocol was designed primarily for facial and scalp actinic keratoses. The newer guidelines recognize that other body sites need more time because the skin is thicker and the immune response takes longer to build.
What Side Effects to Expect
Side effects are generally milder and shorter-lived than with a traditional multi-week fluorouracil course. Common reactions include redness, mild burning or stinging, itching, and some irritation at the treatment site.6PubMed Central. Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article Because you are applying the medication for days rather than weeks, the cumulative irritation is substantially less. The original trial specifically noted that the combination did not produce the pain, crusting, or ulceration that typically makes extended fluorouracil therapy difficult to tolerate.2PubMed Central. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy
That said, do not mistake “milder” for “nothing.” Some degree of redness and peeling is expected in the days following treatment as the immune response kicks in. The T cell activity peaks roughly ten to eleven days after treatment starts, so you may notice the treatment area looking pink or slightly swollen even a week after you stop applying. This is the immune system doing its work, not an allergic reaction or infection. If you develop blistering, open sores, severe swelling, or signs of infection like oozing pus or expanding warmth, contact your dermatologist.
During healing, keep the treated skin moisturized with a bland emollient like plain petroleum jelly or a fragrance-free cream. Avoid harsh cleansers, retinoids, and chemical exfoliants until your skin has fully settled, which typically takes two to three weeks. Sun protection is especially important during and after treatment because the skin barrier is compromised and freshly treated skin is more vulnerable to UV damage.
How Effective Is the Combination at Clearing Lesions
The numbers from the initial randomized trial are striking and vary by body location. On the face, participants saw about an 86% reduction in actinic keratoses with the combination versus 26% with fluorouracil alone. On the scalp, the gap was even wider: roughly 76% versus 6%. On the upper extremities, reductions were 69% and 79% for the right and left arms, respectively, compared with under 16% for fluorouracil alone.1Journal of Investigative Dermatology. Topical calcipotriol plus 5-fluorouracil immunotherapy for non-keratinocyte skin cancers A review of the clinical evidence further confirmed that all trial participants experienced either a reduction in lesion size or complete clearance, with minimal side effects serious enough to halt treatment.6PubMed Central. Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article
The lower clearance rates on the arms and scalp compared with the face are worth noting. Skin on the extremities is thicker and has a different immune environment than facial skin, which is one reason the newer expert guidelines recommend longer treatment durations for non-facial sites. If your main concern is arm lesions, talk to your dermatologist about whether a seven-to-ten-day course is appropriate rather than defaulting to the original four-day protocol.
Long-Term Protection Against Squamous Cell Carcinoma
Clearing actinic keratoses is valuable in itself, but the bigger question for most patients is whether the treatment reduces the risk of developing actual skin cancer down the road. A systematic review found no significant difference in squamous cell carcinoma rates between the combination group and controls at one or two years, but at three years a significant reduction emerged for the face and scalp.7PubMed. Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen’s Disease, and Squamous Cell Carcinoma: A Systematic Review This delayed benefit aligns with the immune memory mechanism described earlier: the memory T cells generated during treatment appear to provide durable surveillance that pays off over time.
Three years is a relatively short follow-up in dermatology, and researchers are watching to see if the protective effect continues or plateaus. For now, the evidence suggests that a single short course is not just a cosmetic fix but a meaningful cancer-prevention step, at least for the face and scalp. Whether repeat courses at intervals could extend the benefit further is still being studied.
Getting the Prescriptions and Insurance Complications
Because this is an off-label combination of two separately approved medications, the prescribing and insurance landscape can be messy. Fluorouracil cream is approved for actinic keratosis treatment, and calcipotriene ointment is approved for plaque psoriasis. Prescribing calcipotriene for actinic keratoses is technically off-label, which means insurance coverage varies. Some plans cover it without issue when the dermatologist documents the indication; others push back.
Compounded versions, where a pharmacy mixes both drugs into a single tube, offer convenience but introduce another insurance hurdle. Compounded prescriptions are frequently not covered by insurance plans, which would lead to underestimates of actual usage when looking at claims data and can leave patients paying out of pocket.4Journal of Investigative Dermatology. Prescription Trends of Fluorouracil with Calcipotriene for Actinic Keratoses in Commercial and Medicare Populations If cost is a concern, getting two separate prescriptions and mixing them yourself at home is functionally identical to the compounded product and often easier to get covered.
Generic versions of both fluorouracil cream and calcipotriene ointment exist, which helps with cost. A tube of generic 5% fluorouracil cream and a tube of generic calcipotriene ointment are both relatively affordable, particularly since a four-to-ten-day treatment course uses much less product than the traditional multi-week fluorouracil regimen.
What About Organ Transplant Recipients
People who have received organ transplants are at dramatically higher risk for skin cancer, often developing aggressive and recurrent squamous cell carcinomas. Their immunosuppressive medications keep the transplanted organ safe but leave the skin far more vulnerable. Whether the fluorouracil-calcipotriene combination works in this population is a high-priority question, because these patients’ suppressed immune systems might not mount the same T cell response that makes the treatment effective in people with healthy immunity.
A Phase IIa clinical trial specifically designed for organ transplant recipients is now underway. The trial is enrolling 56 kidney or lung transplant recipients with actinic keratoses and giving them one or two courses of the combination applied twice daily for six days. The primary question is whether the treatment can still generate the protective CD4+ memory T cells in people taking immunosuppressive drugs. Secondary goals include evaluating whether those T cells persist at six months, how well actinic keratoses clear across different body sites, and safety.8Journal of Investigative Dermatology. A Phase IIa Open-Label Clinical Trial of Calcipotriene Plus 5-Fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients Enrollment began in August 2024 and results have not yet been published. Until that data is in, transplant recipients considering this treatment should discuss it carefully with both their dermatologist and their transplant team.
Uses Beyond Actinic Keratoses
While actinic keratoses are by far the most-studied use for this combination, dermatologists have started exploring it for other conditions that respond to immune activation in the skin. One published case series described three women with extramammary Paget disease, a rare skin cancer that had recurred after surgery and radiation and was resistant to imiquimod cream. All three were switched to a 1:1 mixture of fluorouracil and calcipotriene applied with varying schedules ranging from one to two days per month to four consecutive days every two weeks. All three showed clinical improvement in symptoms and appearance, and two of the three had measurable decreases in tumor burden on biopsy.9JAMA Dermatology. Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease
Three patients is far too few to draw broad conclusions, but the case series illustrates the principle underlying this combination therapy: by recruiting the immune system rather than relying solely on cytotoxic cream, it can sometimes work where standard topical treatments have failed. Research into additional applications, including other superficial skin cancers and precancerous conditions, is still in early stages.
Practical Tips for a Smoother Treatment Course
A few details that do not always make it into the clinical literature but matter in practice:
- Timing your course: Because your skin will look red and feel sensitive for a couple of weeks after treatment, plan around social and professional commitments. Many patients prefer to start on a Thursday or Friday so the active application days fall partly over a weekend.
- Mixing consistency: When mixing the two products at home, aim for a uniform blend. Calcipotriene ointment is greasier than fluorouracil cream, so spend a few seconds working them together on a clean surface or your fingertip before applying.
- Storage: Both products should be stored at room temperature. Calcipotriene can degrade with excessive heat or light exposure, so keep it in its original tube with the cap on when not in use.
- Sun protection: Broad-spectrum sunscreen with SPF 30 or higher should become a daily habit both during and after treatment. If you are applying the combination to your face, apply sunscreen on top once the treatment layer has been absorbed, or use a wide-brimmed hat if layering products feels uncomfortable on irritated skin.
- Do not spot-treat: The whole point of field therapy is to treat subclinical damage you cannot see yet. Resist the temptation to apply only to visible spots; cover the entire area your dermatologist mapped out.
If you are treating both your face and your arms in the same course, remember that the recommended durations differ. You can stop applying to your face after four to five days while continuing on your arms for up to ten days. Your dermatologist should outline this schedule clearly, but it helps to write it down or set phone reminders so you do not accidentally overtreate one area or undertreat another.
How This Compares to Other Field Treatments
For context, the traditional approach to widespread actinic keratoses includes fluorouracil cream alone (applied for two to four weeks), imiquimod cream (applied for weeks to months depending on the protocol), photodynamic therapy (which involves a photosensitizing agent plus a light source), and in-office cryotherapy for individual spots. Each has trade-offs in efficacy, tolerability, cost, and convenience.
The fluorouracil-calcipotriene combination stands out primarily for its short treatment duration and the tolerability advantage. Standard fluorouracil courses lasting two to four weeks are notoriously unpleasant, with significant crusting, oozing, and discomfort that lead many patients to stop early. Imiquimod has its own prolonged course and can cause flu-like symptoms. Photodynamic therapy requires office visits and causes stinging during the light exposure. By contrast, a four-to-ten-day home application with milder side effects is considerably easier to complete, which matters because a treatment that patients actually finish is always more effective in the real world than one they abandon partway through.
The cancer-prevention signal at three years is another distinguishing feature. Standard fluorouracil monotherapy clears visible lesions effectively when used for the full duration, but the evidence that it specifically prevents squamous cell carcinoma years later is less robust. The immune memory generated by adding calcipotriene seems to provide a layer of protection that direct cytotoxicity alone does not.